TAIEquity · Weekly research terminal

1720

Standard Chemical & Pharmaceutical Co., Ltd.

TW Healthcare Drug Manufacturers - Specialty & Generic

Latest week
7 Aug 2026
Weekly close
57.00 TWD
Fair value
52.65 TWD
Next-week expectancy
Undecided 47.67%
Sharemaestro
Weekly Chart Pack Completed weekly market data · Independent research

TAI · Equity · Taiwan

1720

Standard Chemical & Pharmaceutical Co., Ltd.

Healthcare Drug Manufacturers - Specialty & Generic

Standard Chemical & Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese and western medicines, cosmetics, beverages, general instruments, and medical devices. It also provides western pharmaceuticals for cardiovascular, metabolic, genitourinary and sex steroids, respiratory, musculoskeletal, digestive, nervous, and circulatory systems; anti-infectives and topical medications; and cancer and cancer antiemetic. In addition, the company offers health food products. Further, it is …

Last updated
7 Aug 2026
Exchange
Taiwan Stock Exchange · TAI
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
TWD
Market capitalisation
10,988,017,664
Fair value reference
52.65
Next-week expectancy
Undecided · 47.67%

Over the latest 12 completed weeks ending 2026-08-07, 1720 rose 4.59%, moving from 54.50 to 57.00. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is -21.68 and has improved across the 12-week window. Market Dynamics is 1.02 on the latest week. Next-week expectancy is undecided at 47.67% based on similar historical setup states.

Week Ending
7 Aug 2026
Latest Close
57.00
12-Week Change
4.59%
Trend Signal
Active
Next-Week Expectancy
Undecided 47.67%
Signal Weeks
12 of 12

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
7 Aug 2026
Latest Close
57.00
12-Week Change
4.59%
Trend Signal
Active
Next-Week Expectancy
Undecided 47.67%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
-21.68
Market Dynamics
1.02

Over the latest 12 completed weeks ending 2026-08-07, 1720 rose 4.59%, moving from 54.50 to 57.00. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is -21.68 and has improved across the 12-week window. Market Dynamics is 1.02 on the latest week. Next-week expectancy is undecided at 47.67% based on similar historical setup states.

Industry Peers

Taiwan equities in Drug Manufacturers - Specialty & Generic

Stock Exchange Week Open High Low Close Change
6446 PharmaEssentia Corporation TAI 7 Aug 2026 1100.00 1390.00 1090.00 1240.00 12.73%
4119 SCI Pharmtech, Inc. TAI 7 Aug 2026 47.20 51.60 47.00 51.60 9.32%
6472 Bora Pharmaceuticals Co., Ltd. TAI 7 Aug 2026 383.00 430.00 382.50 417.50 9.01%
1795 Lotus Pharmaceutical Co., Ltd. TAI 7 Aug 2026 175.00 192.00 174.50 188.00 7.43%
4746 Formosa Laboratories, Inc. TAI 7 Aug 2026 50.70 54.90 50.50 54.00 6.51%
3054 LIWANLI Innovation Co., Ltd. TAI 7 Aug 2026 48.00 50.90 47.20 50.20 4.58%
1731 MAYWUFA CO TAI 7 Aug 2026 20.65 21.75 20.40 21.10 2.18%
1760 Panion & Bf Biotech Inc. TAI 7 Aug 2026 58.50 60.20 58.10 59.10 1.03%
3705 YungShin Global Holding Corporation TAI 7 Aug 2026 53.60 53.80 52.80 53.50 -0.19%
1707 Grape King Bio Ltd TAI 7 Aug 2026 89.50 90.60 88.20 89.20 -0.34%
4108 PhytoHealth Corporation TAI 7 Aug 2026 11.20 11.45 11.00 11.15 -0.45%
1789 ScinoPharm Taiwan, Ltd. TAI 7 Aug 2026 19.25 19.50 18.30 18.90 -1.82%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context